Literature DB >> 16162712

Mild and moderate-to-severe COPD in nonsmokers: distinct demographic profiles.

Carolyn E Behrendt1.   

Abstract

STUDY
OBJECTIVE: To investigate the risk of COPD among nonsmokers.
DESIGN: Case-control study, logistic regression analysis.
SETTING: Third National Health and Nutrition Examination Survey, from 1988 to 1994. PARTICIPANTS: Community residents 18 to 80 years of age, of white, black, or Mexican-American ethnicity. Nonsmokers included never-smokers and former smokers with a < 5 pack-year smoking history who had never smoked cigars or pipes. MEASUREMENTS: COPD (FEV1/FVC < 70%) was classified as mild (FEV1 > or = 80% predicted) or moderate to severe (FEV1 23 to 79% predicted).
RESULTS: Among 13,995 examinees, 51.3 +/- 0.4% were female, mean age was 42.2 +/- 0.4 years, 48.7 +/- 0.9% were nonsmokers, 8.8 +/- 0.3% had mild COPD, and 4.1 +/- 0.3% had moderate-to-severe COPD [+/- SE]. One fourth of mild and moderate-to-severe cases were nonsmokers. Among 7,526 nonsmokers, 4.7 +/- 0.3% had mild COPD (n = 403; age, 60.9 +/- 1.3 years) and were mostly female (82.5%), while 1.9 +/- 0.3% had moderate-to-severe COPD (n = 92, age 39.3 +/- 1.3) and were mostly male (88.1%). Few nonsmokers with COPD (12.1 +/- 2.4%) had a previous diagnosis of chronic bronchitis or emphysema. Among nonsmokers, physician-diagnosed asthma increased the risk of mild and especially of moderate-to-severe COPD. Independently of asthma, risk of mild COPD in nonsmokers increased with age (doubling every 12 years), before age 60 was lower among men than women, and was inversely associated with current exposure to tobacco smoke at home and at work. In contrast, the risk of moderate-to-severe COPD in nonsmokers was markedly associated with male gender, peaked in middle age, and was inversely associated with nonwhite ethnicity. COPD risks did not vary by minimal smoking history, longest-held occupation, urban residence, income, allergies, thyroid disease, or Helicobacter pylori antibody.
CONCLUSIONS: Among nonsmokers, mild and moderate-to-severe COPD are associated with asthma but otherwise have distinct demographic profiles, suggesting that moderate-to-severe disease is not a mere progression of mild COPD.

Entities:  

Mesh:

Year:  2005        PMID: 16162712     DOI: 10.1378/chest.128.3.1239

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  52 in total

1.  Passive smoking and chronic obstructive pulmonary disease mortality: findings from the Japan collaborative cohort study.

Authors:  Shigekazu Ukawa; Akiko Tamakoshi; Hiroshi Yatsuya; Kazumasa Yamagishi; Masahiko Ando; Hiroyasu Iso
Journal:  Int J Public Health       Date:  2017-02-17       Impact factor: 3.380

2.  Aging adversely affects the cigarette smoke-induced glutathione adaptive response in the lung.

Authors:  Neal S Gould; Elysia Min; Steven Gauthier; Hong Wei Chu; Richard Martin; Brian J Day
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

3.  Respiratory impairment and COPD hospitalisation in older persons: a competing risk analysis.

Authors:  Carlos A Vaz Fragoso; John Concato; Gail McAvay; Peter H Van Ness; Thomas M Gill
Journal:  Eur Respir J       Date:  2012-01-20       Impact factor: 16.671

Review 4.  Novel drug delivery systems targeting oxidative stress in chronic obstructive pulmonary disease: a review.

Authors:  You Xu; Hongmei Liu; Lei Song
Journal:  J Nanobiotechnology       Date:  2020-10-19       Impact factor: 10.435

Review 5.  T-cell biology in aging, with a focus on lung disease.

Authors:  Naeun Lee; Min Sun Shin; Insoo Kang
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-05       Impact factor: 6.053

6.  Handgrip strength measurement as a predictor for successful dry powder inhaler treatment: application in older individuals with COPD.

Authors:  H Frohnhofen; O Hagen
Journal:  Z Gerontol Geriatr       Date:  2011-08       Impact factor: 1.281

Review 7.  Beyond the stomach: an updated view of Helicobacter pylori pathogenesis, diagnosis, and treatment.

Authors:  Traci L Testerman; James Morris
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 8.  DNA sequence variations of metalloproteinases: their role in asthma and COPD.

Authors:  Fotis Sampsonas; Alexander Kaparianos; Dimosthenis Lykouras; Kiriakos Karkoulias; Kostas Spiropoulos
Journal:  Postgrad Med J       Date:  2007-04       Impact factor: 2.401

9.  Exposure to PM10 as a risk factor for the development of nasal obstruction and chronic obstructive pulmonary disease.

Authors:  Lazaros Sichletidis; Dionisios Spyratos; Anastasios Tsiotsios; Anna-Bettina Haidich; Ioannis Ganidis; Dimitrios Michailidis; Georgios Triantafyllou; George Kottakis; Dimitrios Melas
Journal:  Int J Occup Environ Health       Date:  2014 Jan-Mar

Review 10.  The aging immune system and its relationship to the development of chronic obstructive pulmonary disease.

Authors:  Gulshan Sharma; Nicola A Hanania; Y Michael Shim
Journal:  Proc Am Thorac Soc       Date:  2009-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.